Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP808940.RAHrLK8rxxDG6JOGxERar8sw3mRecSzCTUMFlZPdFR7hA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP808940.RAHrLK8rxxDG6JOGxERar8sw3mRecSzCTUMFlZPdFR7hA130_assertion type Assertion NP808940.RAHrLK8rxxDG6JOGxERar8sw3mRecSzCTUMFlZPdFR7hA130_head.
- NP808940.RAHrLK8rxxDG6JOGxERar8sw3mRecSzCTUMFlZPdFR7hA130_assertion description "[To determine whether CCL2 mRNA expression is beneficial or detrimental for cervical cancer patients, the association between the expression of this molecule by cervical tumour cells, the number of tumour-associated macrophages, and clinicopathological parameters such as recurrence, relapse-free survival, and overall patient survival was investigated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808940.RAHrLK8rxxDG6JOGxERar8sw3mRecSzCTUMFlZPdFR7hA130_provenance.
- NP808940.RAHrLK8rxxDG6JOGxERar8sw3mRecSzCTUMFlZPdFR7hA130_assertion evidence source_evidence_literature NP808940.RAHrLK8rxxDG6JOGxERar8sw3mRecSzCTUMFlZPdFR7hA130_provenance.
- NP808940.RAHrLK8rxxDG6JOGxERar8sw3mRecSzCTUMFlZPdFR7hA130_assertion SIO_000772 16435282 NP808940.RAHrLK8rxxDG6JOGxERar8sw3mRecSzCTUMFlZPdFR7hA130_provenance.
- NP808940.RAHrLK8rxxDG6JOGxERar8sw3mRecSzCTUMFlZPdFR7hA130_assertion wasDerivedFrom befree-20140225 NP808940.RAHrLK8rxxDG6JOGxERar8sw3mRecSzCTUMFlZPdFR7hA130_provenance.
- NP808940.RAHrLK8rxxDG6JOGxERar8sw3mRecSzCTUMFlZPdFR7hA130_assertion wasGeneratedBy ECO_0000203 NP808940.RAHrLK8rxxDG6JOGxERar8sw3mRecSzCTUMFlZPdFR7hA130_provenance.